Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The haemophilia certification system in Canada.
Matino D, Teitel J, Page D, Keepanasseril A, Iorio A, Walker I. Matino D, et al. Among authors: keepanasseril a. Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):e531-41. doi: 10.2450/2014.0032-14s. Blood Transfus. 2014. PMID: 24922284 Free PMC article. Review. No abstract available.
Interventions for enhancing medication adherence.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Nieuwlaat R, et al. Among authors: keepanasseril a. Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4. Cochrane Database Syst Rev. 2014. PMID: 25412402 Free PMC article. Review.
Switching to extended half-life products in Canada - preliminary data.
Keepanasseril A, Stoffman J, Bouskill V, Carcao M, Iorio A, Jackson S; Association of Hemophilia Centre Directors of Canada (AHCDC). Keepanasseril A, et al. Haemophilia. 2017 Jul;23(4):e365-e367. doi: 10.1111/hae.13245. Epub 2017 May 26. Haemophilia. 2017. PMID: 28548284 No abstract available.
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective study.
Matino D, Iorio A, Keepanasseril A, Germini F, Caillaud A, Carcao M, Hews-Girard J, Iserman E, James P, Lee A, Phua CW, Sun HL, Teitel J, Poon MC. Matino D, et al. Among authors: keepanasseril a. Res Pract Thromb Haemost. 2022 Mar 31;6(3):e12661. doi: 10.1002/rth2.12661. eCollection 2022 Mar. Res Pract Thromb Haemost. 2022. PMID: 35386274 Free PMC article.
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature.
Germini F, Noronha N, Abraham Philip B, Olasupo O, Pete D, Navarro T, Keepanasseril A, Matino D, de Wit K, Parpia S, Iorio A. Germini F, et al. Among authors: keepanasseril a. J Thromb Haemost. 2022 Jun;20(6):1364-1375. doi: 10.1111/jth.15723. Epub 2022 Apr 23. J Thromb Haemost. 2022. PMID: 35395700 Free article. Review.
Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes.
Iorio A, MacDonald V, Caillaud A, Luckevich MD, Christoffersen P, Matino D, Keepanasseril A, Iserman E, Germini F, Bentley A, Poon MC. Iorio A, et al. Among authors: keepanasseril a. Res Pract Thromb Haemost. 2023 Mar 11;7(3):100106. doi: 10.1016/j.rpth.2023.100106. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37065846 Free PMC article.
106 results